Last edition
News about "Syantra"
Syantra, Inc., a cancer diagnostics innovator, has launched a new therapeutic division aimed at developing first-in-class immuno-oncology therapies to reprogram tumour-affected immune cells and restore anti-cancer immunity.
Syantra | 05/09/2025 | By Mrinmoy Dey | 123
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members